BriaCell Therapeutics Corp. - BCTXL

Sector: Healthcare · Industry: Biotechnology
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q2 2026 · Q1 2026
Value (USD)
Total reported value ($000)
$2.529M
QoQ value delta ($000)
-$1.163M (-31.5%)
Implied price effect (QoQ)
-17.18%
Shares
Total shares
2,955,899
QoQ shares delta
-618,031 (-17.29%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (BCTXL)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q2 2026)

Top 25 only Full list
Manager Value ($000) Shares % of 13F
CITADEL ADVISORS LLC 716 895,864 0.0%
ARMISTICE CAPITAL, LLC 477 536,600 0.01%
Cable Car Capital, LP 286 321,898 0.01%
Empery Asset Management, LP 267 300,000 0.31%
MYDA Advisors LLC 174 195,821 0.03%
SABBY MANAGEMENT, LLC 169 190,383 0.15%
HEIGHTS CAPITAL MANAGEMENT, INC 149 186,582 0.03%
Warberg Asset Management LLC 142 159,555 0.03%
Clear Street Group Inc. 92 104,196 0.0%
IRIDIAN ASSET MANAGEMENT LLC/CT 57 65,000 0.02%